Drug Lice Treatment Recalled Due to Manufacturing Practice Violations
Neogen Corporation has voluntarily recalled LICEOUT liquid lice treatment due to manufacturing practice violations. The recall affects 8,328 jugs distributed to institutions.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II voluntary recall due to manufacturing practice violations with no reported illnesses or injuries. The recall is precautionary and addresses process compliance issues rather than a specific identified product hazard.
Plain-English summary
Neogen Corporation has voluntarily recalled LICEOUT, a liquid lice treatment for human use, due to Current Good Manufacturing Practices (CGMP) violations. The recall includes 8,328 jugs distributed through Bob Barker Company, Inc., which supplies institutional facilities.
The Food and Drug Administration classified this as a Class II recall. The recall was initiated on October 8, 2024, and is ongoing.
Affected product includes specific lot numbers (LO09530, LO13412, LO10263, LO11303, LO12153, LO12483, LO13183, LO106024, LO108624, and LO110224) with expiration dates ranging from November 3, 2024, through April 11, 2026. Institutions that received this product should not use it and should contact Neogen Corporation or the FDA for information regarding the recall and available alternatives.
The recalled product
- Product
- LICEOUT, Liquid Lice Treatment for Human Use, Contents: 128 FL OZ. (3785.4 mL mL) per jug, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526. NDC: 53247-124-02
- Manufacturer
- Neogen Corporation
- Category
- Drug — Topical Lice Treatment
- Hazard
- Affected units
- 8,328
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot
- expiry: LO09530
- exp 11/3/2024
- LO13412
- exp 12/7/2024
- LO10263
- exp 1/26/2025
- LO11303
- exp 5/10/2025
- LO12153
- exp 8/3/2025
- LO12483
- exp 9/5/2025
- LO13183
- exp 11/14/2025
- LO106024
- exp 2/29/2026
- LO108624
- exp 3/26/2026
- LO110224
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by Neogen Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Neogen Corporation
See all →- ModerateFDA Drug Recall: LICEOUT Liquid Lice Treatment for Manufacturing Violations
FDA (Drugs) · 2024-12-04
Same hazard · manufacturing defect
See all →- ModerateBoston Scientific Recalls NaviFlex LW Pusher and Advx Panc. Stent
FDA (Devices) · 2026-10-21
- ModerateCook Williams Cystoscopic Injection Needles Recalled for Manufacturing Defect
FDA (Devices) · 2026-10-21
- ModerateNeuronetics Recalls NeuroStar Advanced Therapy Systems Due to Non-Conforming Cables
FDA (Devices) · 2026-10-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-10-14
- ModerateCustom Interventional Pain Management Recalls Mastisol Skin Adhesive Trays
FDA (Devices) · 2026-10-07
Similar recalls
- ModerateLidocaine Oral Topical Solution Recalled Due to Failed Viscosity Specification
FDA (Drugs) · 2022-05-11
- ModerateAcetaminophen Oral Solution Recalled Due to Manufacturing Control Deviations
FDA (Drugs) · 2022-09-14
- SevereLannett Recalls Levetiracetam Oral Solution Due to Microbial Contamination
FDA (Drugs) · 2019-12-25
- HighAcetaminophen Oral Solution Recalled for Manufacturing Process Control Failures
FDA (Drugs) · 2022-09-14
- ModerateAkorn Recalls Levetiracetam Oral Solution Due to Leaking Bottles
FDA (Drugs) · 2021-01-20
- ModeratePharmatech Recalls Senexon Liquid Due to Potential B. cepacia Contamination
FDA (Drugs) · 2016-10-05